A natural compound induced cardiogenic differentiation of endogenous MSCs for repair of infarcted heart

Differentiation

Volumn 83, Issue 1, 2012, Pages 1-9

  Lin, Xiaoli ^a   Peng, Peng ^a,b   Cheng, Lei ^b,c   Chen, Shihui ^d   Li, Karen ^d   Li, Zhong Yu ^a   Mo, Ye Hua ^a,b   Zhou, Zhen ^a   Li, Ming ^a,b  

^a Laboratory of Innovative Medicine   (Hong Kong)

^b JINAN UNIVERSITY   (China)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiac myocytes; Cardiogenic differentiation; Mesenchymal stem cells; Myocardial infarction; Myocardial regeneration

Indexed keywords

CARDIOGENIN; CARDIOVASCULAR AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CELL DIFFERENTIATION; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFICACY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; BONE MARROW TRANSPLANTATION; CADHERINS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; GEUM; MALE; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; SAPONINS; WHOLE-BODY IRRADIATION;

RATTUS;

EID: 80053438062     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.09.001     Document Type: Article

References (32)

1. American Heart Association. Cardiovascular disease statistics. Available at (accessed March 2, 2009). http://www.americanheart.org/presenter.jhtml?identifier=4478.
2. Anversa P., Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ. Res. 1998, 83:1-14.
3. Amabile G., Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol. Med. 2009, 15:59-68.
4. Andrews P.W., Matin M.M., Bahrami A.R., Damjanov I., Gokhale P., Draper J.S. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem. Soc. Trans. 2005, 33:1526-1530.
5. Allers C., Sierralta W.D., Neubauer S., Rivera F., Minguell J.J., Conget P.A. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004, 78:503-508.
6. Bangdiwala S.I., Weiner D.H., Bourassa M.G., Friesinge G.C., Ghali J.K., Yusuf S. Studies of left ventricular dysfunction (SOLVD) registry: rationale, design, methods and description of baseline characteristics. Am. J. Cardiol. 1992, 70:347-353.
7. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., Nadal-Ginard B., Silvestri F., Leri A., Beltrami C.A., Anversa P.E. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 2001, 344:1750-1757.
8. Baddoo M., Hill K., Wilkinson R., Gaupp D., Hughes C., Kopen G.C., Phinney D.G. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell Biochem. 2003, 89:1235-1249.
9. Cheng L., Chen H., Yao X.S., Qi G.Q., Liu H.W., Lee K.M., Lee K.H., Zhang J.T., Chen S.H., M.L. A plant-derived remedy for repair of infarcted heart. Plos One 2009, V4(2):e4461.
10. Cheng L., Gu X.M., Sanderson J.E., Wang X., Lee K., Yao X.S., Liu H.W., Cheung W.L., Li M. A new function of a previously isolated compound that stimulates activation and differentiation of myogenic precursor cells leading to efficient myofiber regeneration and muscle repair. Int. J. Biochem. Cell Biol. 2006, 38:1123-1133.
11. Chen, H., Peng, P., Cheng, L., Lin, X.L., Chung, S.S.W., Li, M.. Reconstitution of coronary vasculature in ischemic hearts by plant-derived angiogenic compounds. Int. J. Cardio. 23, in press.
12. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., Kloner R.A. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005, 112:214-223.
13. Delaloy C., Gao F.B. A new role for microRNA-9 in human neural progenitor cells. Cell Cycle 2010, 9:2913-2914.
14. Delaloy C., Liu L., Lee J.A., Su H., Shen F., Yang G.Y., Young W.L., Ivey K.N., Gao F.B. MicroRNA-9 coordinates proliferation and migration of human embryonic stem cells-derived neural progenitors. Cell Stem Cell 2010, 6:323-335.
15. Erices A.A., Allers C.I., Conget P.A., Rojas C.V., Minguell J.J. Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion. Cell Transplant. 2003, 12:555-561.
16. Fukuda K. Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenit. Anom. 2002, 42:1-9.
17. Fukuda K. Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow Transplant. 2003, 32:S25-S27.
18. Grove J.E., Bruscia E., Krause D.S. Plasticity of bone marrow derived stem cells. Stem Cells 2004, 22:487-500.
19. Horwitz E.M. Stem cell plasticity: the growing potential of cellular therapy. Arch. Med. Res. 2003, 34:600-606.
20. Hodgson D.M., Behar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., Puceat M., Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H471-H479.
21. Jovanovic M., Reiter L., Picotti P., Lange V., Bogan E., Hurschler B.A., Blenkiron C., Lehrbach N.J., Ding X.C., Weiss M., Schrimpf S.P., Miska E.A., Großhans H., Aebersold R., Hengartner M.O. A quantitative targeted proteomics approach to validate predicted microRNA targets in C. elegans. Nat. Methods 2010, 7:837-842.
22. Kollet O., Spiegel A., Peled A., Petit I., Byk T., Hershkoviz R., Guetta E., Barkai G., Nagler A., Lapidot T. Rapid and efficient homing of human CD34+CD38-/lowCXCR4+stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice. Blood 2001, 97:3283-3291.
23. Li M., Yu C.M., Cheng L., Wang M., Gu X.M., Lee K.H., Wang T., Sung Y.T., Sanderson J.E. Repair of infarcted myocardium by an extract of Geum japonicum with dual effects on angiogenesis and myogenesis. Clin. Chem. 2006, 52:1460-1468.
24. Min J.Y., Yang Y., Converso K.L., Liu L., Huang Q., Morgan J.P., Xiao Y.F. Transplantation of embryonic stem cells improves cardiac function in post-infarcted rats. J. Appl. Physiol. 2002, 92:288-296.
25. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., Entman M.L., Schneider M.D. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 2003, 100:12313-12318.
26. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
27. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 2004, 95:9-20.
28. Rodolfa K., Di Giorgio F.P., Sullivan S. Defined reprogramming: a vehicle for changing the differentiated state. Differentiation 2007, 75:577-579.
29. Siminiak T., Kalawski R., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., Kurpisz M. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am. Heart J. 2004, 148:531-537.
30. Severin Z., Wang M.Y., Gaustad P., Kvalheim G., Rolstad B., Vaage J.T. Mycoplasma contamination revisited: mesenchymal stromal cells harboring mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro. Plos One 2011, V6(1):e16005.
31. Trounson A. The production and directed differentiation of human embryonic stem cells. Endocr. Rev. 2006, 27:208-219.
32. Wu D.C., Byod A.S., Wood K.J. Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front Biosci. 2007, 12:4525-4535.